Healthcare giant McKesson Corp. plans an aggressive move into venture capital funding for healthcare technology, planning to commit several hundred million dollars over the next five to eight years and hiring a VC industry veteran to head its VC initiative.
Healthcare giant McKesson Corp. plans an aggressive move into venture capital funding for healthcare technology, expecting to commit several hundred million dollars to the effort over the next five to eight years, and hiring long-time venture capitalist Tom Rodgers as managing director of strategic...
Efforts to bring an Internet-based solution to healthcare's lackluster capability to exchange electronic information has gained momentum with the cooperation of five rival developers of electronic health-record companies and four large, tech-savvy health systems.
Healthcare stocks are attracting the big-money crowd, a sign that serious investors think there's money to be made in the sector, according to one tracker of where billionaires invest.
Most healthcare providers feel pretty good about the progress they've made on the path toward interoperability of their healthcare information technology, even though the majority of them know they still have a long way to go to achieve full information exchange.
McKesson Corp.'s earnings rebounded during the second quarter of its fiscal year as its Celesio acquisition and growth in market share helped the San Francisco-based company realize $469 million in net income. Being an authorized distributor of Sovaldi likely helped as well.
There is interoperability in American healthcare, more than is generally thought, a federal health IT official and multiple advisers noted during a rare joint meeting Wednesday of the two main federally chartered health information technology advisory panels.
The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.
McKesson Corp. will pay the federal government $18 million to settle allegations tied to a whistle-blower lawsuit. The suit involved a company shipping contract with the Centers for Disease Control and Prevention.
McKesson Corp.'s earnings fell 5% in its fiscal first quarter, despite double-digit growth in its distribution segment, as charges related to its international technology business and certain one-time items dragged down the company's bottom line.
Dr. Emad Rizk is set to assume leadership of hospital revenue-management company Accretive Health on July 21. Modern Healthcare recently interviewed Rizk about the revolution afoot in healthcare payment, with providers on a fast and rocky path from fee-for-service to value- based models.
McKesson Corp. Chairman and CEO John Hammergren earned $25.9 million in the company's fiscal 2014—a 50% drop from when he took home a highly criticized $51.7 million compensation package in 2013.